Magnesium's Role in Energy Production: The Mg-ATP Complex
The statement that magnesium is required for ATP synthesis understates the relationship. More precisely: free ATP⁴⁻ does not exist in significant quantities in living cells. ATP in biological systems is essentially always chelated to a Mg²⁺ ion, forming Mg-ATP²⁻. The Mg²⁺ ion bridges between the β- and γ-phosphate groups of ATP, stabilizing the molecule and making the terminal phosphate accessible for hydrolysis. ATP-utilizing enzymes (kinases, ATPases) bind the Mg-ATP complex, not free ATP.
This has several implications:
- Intracellular free Mg²⁺ concentration directly regulates the availability of functional ATP — even if ATP is synthesized, it's non-functional without Mg²⁺ chelation
- Magnesium deficiency impairs energy transduction at the most fundamental biochemical level — affecting every cell in the body simultaneously
- The mitochondrial F₁F₀-ATP synthase requires Mg²⁺ for the rotary catalytic mechanism that phosphorylates ADP → ATP; the αβ subunit active sites coordinate Mg²⁺ during catalysis
- Creatine phosphate (the immediate ATP regeneration system in muscle) requires creatine kinase, which is a Mg²⁺-dependent enzyme — explaining why Mg deficiency impairs peak power output and rapid exercise recovery
Magnesium Forms: Bioavailability and Target Applications
Magnesium Oxide (MgO)
The elemental magnesium content of MgO is high (~60%), making it appear attractive on supplement labels. But the low solubility in gastric fluid (~0.6g/L at pH 2) severely limits bioavailability. Most arrives intact in the colon, drawing water osmotically and causing the laxative effect. Bioavailability relative to magnesium chloride: ~4% in controlled studies. The one legitimate use: as an osmotic laxative (milk of magnesia, MiraLax). Not recommended as a primary magnesium supplement for systemic deficiency repletion.
Magnesium Glycinate (Magnesium Bisglycinate)
Two glycine molecules chelated to Mg²⁺. The chelation protects Mg²⁺ from forming insoluble complexes with phytates, phosphates, or oxalates in the GI tract. Glycine — an inhibitory amino acid and GABA coagonist — adds its own CNS effects: glycine activates the strychnine-sensitive glycine receptor (GlyR), which hyperpolarizes neurons and has anti-anxiety and sleep-promoting properties. The combination of well-absorbed magnesium + glycine's relaxing properties makes bisglycinate the preferred form for evening use targeting sleep and anxiety. Relative bioavailability: ~80% vs magnesium chloride in crossover studies. Minimal laxative effect at doses up to 400mg elemental Mg/day.
Magnesium Malate
Magnesium chelated to malic acid. Malate is a Krebs cycle intermediate — it is directly metabolized in mitochondria as a TCA cycle substrate. This makes malate particularly relevant for energy production and may explain anecdotal reports of increased energy with magnesium malate vs other forms. Magnesium malate has been specifically studied in fibromyalgia patients (Russell 1995, J Rheumatol): 300–600mg Mg with 1,200–2,400mg malic acid reduced pain scores significantly in an open-label study. Some practitioners prefer magnesium malate for morning use to avoid the sedation some users report with glycinate, though this effect is not well-documented in RCTs. Bioavailability is similar to glycinate.
Magnesium L-Threonate (MgT / Magtein)
Developed at MIT (Slutsky 2010, Neuron) specifically to penetrate the blood-brain barrier. The threonate anion exploits SVCT2 transporters on the BBB. In the Slutsky study, MgT increased synapse density in the prefrontal cortex and hippocampus by ~15% and improved performance on working memory and long-term memory tasks in aged rats. The brain Mg concentration rose 18% vs baseline. Human trial: Bagis 2014 showed cognitive improvements in older adults with MgT supplementation (Magtein 1.5–2g/day). The elemental magnesium content per capsule is lower than other forms (~144mg/2g MgT), requiring larger or more capsules. Most appropriate for cognitive performance and neuroprotective applications. Significantly more expensive than other forms.
Magnesium Citrate
Highly water-soluble and well-absorbed (~66% relative bioavailability). The most common "better than oxide" form found in pharmacies. Some osmotic laxative effect at higher doses but far less than oxide. The citrate anion alkalinizes urine, which may reduce kidney stone risk in calcium oxalate stone formers (by increasing urinary citrate, an inhibitor of stone nucleation). A reasonable default choice when cost matters. Not optimized for any specific target (CNS, energy, sleep) vs glycinate or malate.
| Magnesium Form | Relative Bioavailability | Best Application | Notes |
|---|---|---|---|
| Oxide | ~4% (poor) | Osmotic laxative only | 60% elemental content; most multivitamins use this — essentially no systemic benefit for Mg repletion; avoid as a supplement |
| Citrate | ~66% (good) | General Mg repletion, kidney stone prevention | Most accessible improved-bioavailability form; mild laxative at high doses; reasonable cost; alkalinizes urine |
| Glycinate / Bisglycinate | ~80% (excellent) | Sleep, anxiety, muscle recovery, evening use | Best-tolerated high-absorption form; glycine's GlyR activity adds relaxation; minimal GI side effects; evening dosing preferred |
| Malate | ~80% (excellent) | Energy, fibromyalgia, morning use | Malic acid is Krebs cycle substrate; may improve energy production; studied in fibromyalgia; morning dosing is reasonable |
| L-Threonate (MgT) | ~80% systemic; only form raising CSF Mg | Cognitive performance, neuroprotection | Lower elemental Mg per capsule; significantly more expensive; BBB penetration via SVCT2; synapse density evidence in animal models |
| Taurate | ~70% estimated | Cardiovascular, blood pressure | Taurine has independent cardiovascular benefits; Mg taurate is studied for blood pressure; limited standalone human RCT data |
Magnesium Protocol by Goal: Evidence-Based Dosing and Form Selection
- Sleep and anxiety — magnesium glycinate, 200–400mg elemental Mg, 30–60 min before bed: The glycine component activates inhibitory glycine receptors and potentiates GABA-A activity, while Mg²⁺ itself blocks NMDA receptors (reducing excitatory glutamate tone). Abbasi 2012 (J Res Med Sci, n=46 elderly with insomnia) showed 500mg/day magnesium improved sleep quality scores, reduced cortisol, reduced serum renin, and increased melatonin. Start at 200mg elemental Mg as glycinate and titrate up based on effect. Avoid oxide or citrate at night due to potential GI urgency.
- Migraine prophylaxis — 400–600mg elemental Mg/day: Any well-absorbed form works. Peikert 1996 used magnesium dihydrogen phosphate; Facchinetti 1991 used Mg pyrrolidone carboxylic acid. Meta-analyses confirm any absorbable Mg form at ≥400mg/day significantly reduces migraine frequency after 2–3 months of consistent use. If tolerating GI effects, split into 200mg morning + 200mg evening. IV magnesium sulfate (1g over 15 minutes) is effective for acute migraine with aura in emergency settings.
- Cognitive performance and aging — magnesium L-threonate (Magtein), 1.5–2g/day (providing ~144mg elemental Mg): Typically dosed as 1 capsule morning + 2 capsules evening. The higher evening dose exploits synergies with sleep (the main period of synaptic consolidation). This is the most expensive and most targeted option — not justified for general Mg repletion, but potentially valuable for individuals specifically targeting memory and cognitive aging. Combine with general Mg glycinate if total Mg intake is low.
- Athletic performance and muscle recovery — magnesium malate or glycinate, 300–400mg elemental Mg/day: Magnesium is required for creatine kinase (rapid ATP regeneration), Na/K-ATPase (electrolyte balance), and reduces post-exercise creatine kinase (muscle damage marker). Athletes have higher urinary Mg losses — especially with heavy sweating. Morning malate + evening glycinate is a practical combination. Do not take with calcium supplements (competitive absorption at intestinal transporters) — separate by 2+ hours.
- Signs of deficiency to watch for: Muscle cramps (especially nocturnal calf cramps — almost pathognomonic for Mg deficiency), eyelid twitching (orbicularis oculi fasiculations), constipation, low energy, palpitations, poor sleep quality, and anxiety. Serum Mg is a poor marker for intracellular status (only 1% of body Mg is extracellular); RBC magnesium or 24-hour urinary Mg excretion are better functional tests. Serum Mg can be normal while tissue stores are depleted.
Look for: "magnesium bisglycinate" or "magnesium glycinate chelate" — these are equivalent. Verify the elemental magnesium content per serving (target 200–400mg/day). Avoid products listing "magnesium amino acid chelate" without specifying the amino acid — this is often oxide in a weak glycine chelate. Doctors Best, NOW Foods Magnesium Bisglycinate, and Thorne Magnesium Bisglycinate are consistently well-reviewed for purity and label accuracy.
Magtein is the branded form used in the original Slutsky 2010 (Neuron) research. Look for products listing "Magtein" or "magnesium L-threonate" explicitly. Standard human dose: 2,000mg MgT/day providing ~144mg elemental Mg — significantly less elemental Mg than other forms, so stack with glycinate if repleting systemic deficiency simultaneously.